New-age companies went public for the first time, nearly 40 unicorns were minted, and by the end, startups had raised a whopping $36 billio...

"It's a case of capital dumping in these e-pharmacies by foreign behemoths. Which can prove extremely detrimental to the sustenance and fut...

Tata Group is set to invest around $1.2 billion for its entry into digital commerce with majority stakes in e-grocer Bigbasket and e-pharma...

E-pharmacy had over 3 million users before the pandemic struck in India, according to a white paper from industry body Ficci and market res...

India's $20-billion pharmaceutical industry is set for a shakeup as giants Reliance Retail and Amazon chart plans to enter the e-pharmacy s...

Both Amazon and Flipkart's interest in medicine delivery comes at a time when the industry is seeing consolidation with Reliance Industries...

Reliance's yet-to-be announced acquisition of Netmeds for an estimated $120 million is a catalyst for other players such as PharmEasy and M...

The conversations between Reliance and Netmeds, which had also held talks with Walmart-owned Flipkart, had been going on before the coronav...

Firms seek better definition of ‘sensitive’ health data and guidelines for anonymised data in the Personal Data Protection Bill. The clause...

The petition had said certain categories of drugs (schedules H and X) cannot be sold without a prescription, that is, only through physical...

Government yet to finalise amendments to Drugs and Cosmetics Rules, 1945.

Besides, the increase in chronic diseases, rising per capita income and resultant healthcare spend will also aid to its growth.

Netmeds.com also acquired online video consultation app JustDoc last September venturing into healthcare services, diagnostics and consulta...

The interim stay will be in place until the centre notifies statutory rules for online trade of medicines.

The bench has reserved its orders on the plea to stay an earlier court order that banned the sale of medicines online from December 20, whi...

This comes after the Madras High Court, in a recent injunction, restrained unlicenced e-pharmacies from doing business.

The health ministry had on August 28 published the draft guidelines for e-pharma companies, giving stakeholders 45 days to make suggestions.